Does 17-alpha hydroxyprogesterone caproate prevent recurrent preterm birth in obese women?

Heyborne, Kent D; Allshouse, Amanda A; Carey, J Christopher

Heyborne, Kent D; Allshouse, Amanda A; Carey, J Christopher.

Afiliación

Heyborne KD; Department of Obstetrics and Gynecology, Denver Health and Hospital Authority, Denver, CO; Department of Obstetrics and Gynecology, University of Colorado Denver, Denver, CO. Electronic address: kent.heyborne@dhha.org.
Allshouse AA; University of Colorado School of Public Health, Aurora, CO.
Carey JC; Department of Obstetrics and Gynecology, Denver Health and Hospital Authority, Denver, CO; Department of Obstetrics and Gynecology, University of Colorado Denver, Denver, CO.

Am J Obstet Gynecol ; 213(6): 844.e1-6, 2015 Dec.

Article en En | MEDLINE | ID: mdl-26275354

Asunto(s)

Hidroxiprogesteronas/uso terapéutico; Obesidad/complicaciones; Nacimiento Prematuro/prevención & control; Congéneres de la Progesterona/uso terapéutico; Caproato de 17 alfa-Hidroxiprogesterona; Adulto; Índice de Masa Corporal; Femenino; Edad Gestacional; Humanos; Embarazo; Recurrencia

Palabras clave

17-alpha hydroxyprogesterone caproate; body mass index; obesity; prematurity; preterm birth; progesterone

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Congéneres de la Progesterona / Nacimiento Prematuro / Hidroxiprogesteronas / Obesidad Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Límite: Adult / Female / Humans / Pregnancy Idioma: En Revista: Am J Obstet Gynecol Año: 2015 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google